Adcetris Approved for Hodgkin lymphoma and Systemic Anaplastic Large Cell Lymphoma - MPR
Links shared publicly online about this topic.
- 54total visits
Adcetris Approved for Hodgkin lymphoma and Systemic Anaplastic Large Cell Lymphoma - MPR
empr.com —
View full resource at empr.com
Tags: Genetic, Cancer, Lymphoma, Hodgkin Lymphoma, FDA, Genetics
Most Recently Shared on August 22, 2011 at 2:10 pm By:
Adcetris Approved for Hodgkin lymphoma and Systemic Anaplastic Large Cell Lymphoma http://ow.ly/69lQM #lymphoma #adcetris
Enthusiasm for Antibody–Drug Conjugates
jnci.oxfordjournals.org — “Enthusiasm for Antibody–Drug Conjugates” View full resource at jnci.oxfordjournals.org
Most Recently Shared on October 12, 2011 at 1:22 pm By:
FDA approves drug for treating Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large-cell lymphoma http://t.co/R7ruPWGi
FDA approves Seattle Genetics drug for 2 cancers - Forbes.com
forbes.com — “FDA approves Seattle Genetics drug for 2 cancers - Forbes.com” View full resource at forbes.com
Most Recently Shared on August 23, 2011 at 12:25 am By:
Thomas J Reid MD PhD Doctor, PhD, Internist, Oncologist, Hematologist, and Physician
FDA approves Adcetris (brentuximab) to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma. http://t.co/nd8JrjN
FDA Approves New Drug for Lymphoma
webmd.com — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at webmd.com
Most Recently Shared on August 22, 2011 at 6:00 pm By:
RT @webmd: FDA Approves New Drug for Lymphoma http://t.co/evvCAO6
Medical News: Brentuximab Wins FDA Nod for Hodgkin's, ALCL - in Oncology/Hematology, Lymphoma from MedPage Today
medpagetoday.com — “The FDA has approved the biologic drug brentuximab vedotin (Adcetris) for treating Hodgkin's lymphoma and a rare cousin, systemic anaplastic large-cell lymphoma (ALCL).” View full resource at medpagetoday.com
Most Recently Shared on August 20, 2011 at 5:26 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Brentuximab Wins FDA Nod for Hodgkin's, ALCL - in Oncology/Hematology, Lymphoma from MedPage Today - http://t.co/hOHX12u from @medpagetoday
FDA Approves New Drug for Lymphoma - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL). (Source: WebMD Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2011 at 3:00 pm By:
FDA Approves New Drug for Lymphoma: The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin... http://t.co/211DOTP
FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL
news-medical.net — “Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemothe” View full resource at news-medical.net
Most Recently Shared on August 20, 2011 at 7:44 am By:
News-Medical.Net Oncology and Health News
Oncology News: FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL: Seattle Genetics, In... http://t.co/lQmBAUv
Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL
news-medical.net — “The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.” View full resource at news-medical.net
Most Recently Shared on August 20, 2011 at 7:44 am By:
News-Medical.Net Oncology and Health News
Oncology News: Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL: The U.S. Foo... http://t.co/GN8a2fV
FDA Approves Adcetris To Treat Two Types Of Lymphoma
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at medicalnewstoday.com
Most Recently Shared on August 20, 2011 at 7:05 am By:
FDA Approves Adcetris To Treat Two Types Of Lymphoma http://mnt.to/3Z5T #lymphoma #leukemia
FDA Approves New Drug for Lymphoma - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin's lymphoma and a rare type of the disease known as systemic anaplastic large cell lymphoma (ALCL). (Source: WebMD Health)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2011 at 1:00 am By:
FDA Approves New Drug for Lymphoma: The FDA has approved the drug Adcetris to treat two types of lymphoma, Hodgkin... http://t.co/JkP4DIP
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 9:09 pm By:
Drugs and Devices OW OW Health
FDA Approves Adcetris to Treat Two Types of Lymphoma: August 19, 2011 - The U.S. Food and Drug Administrat... http://t.co/QLmCG1d #drug
Adcetris (Brentuximab Vedotin) Approved For Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma - FDA
medicalnewstoday.com — “The FDA has approved brentuximab vedotin, brand name Adcetris, for the treatment of HL (Hodgkin lymphoma) and ALCL (systemic anaplastic large cell lymphoma). Adcetris consists of a drug and an ant” View full resource at medicalnewstoday.com
Most Recently Shared on August 19, 2011 at 9:05 pm By:
Adcetris (Brentuximab Vedotin) Approved For Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma - FDA http://mnt.to/3Z5F
FDA Approves Adcetris to Treat Two Types of Lymphoma
drugs.com — “Adcetris (brentuximab vedotin) is used to treat Hodgkin lymphoma and systemic anaplastic large cell lymphoma . Includes Adcetris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 19, 2011 at 8:34 pm By:
FDA Approves Adcetris to Treat Two Types of Lymphoma - http://t.co/4maXtfp
Medical News: Brentuximab Wins FDA Nod for Hodgkin's, ALCL - in Oncology/Hematology, Lymphoma from MedPage Today
medpagetoday.com — “The FDA has approved the biologic drug brentuximab vedotin (Adcetris) for treating Hodgkin's lymphoma and a rare cousin, systemic anaplastic large-cell lymphoma (ALCL).” View full resource at medpagetoday.com
Most Recently Shared on August 19, 2011 at 8:18 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Brentuximab Wins FDA Nod for Hodgkin's, ALCL - in Oncology/Hematology, Lymphoma from MedPage Today - http://t.co/BO3IcZO from @medpagetoday
Brentuximab Wins FDA Nod for Hodgkin's, ALCL - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The FDA has approved the biologic drug brentuximab vedotin (Adcetris) for treating Hodgkin's lymphoma and a rare cousin, systemic anaplastic large-cell lymphoma (ALCL).” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2011 at 8:00 pm By:
Brentuximab Wins FDA Nod for Hodgkin's, ALCL: (MedPage Today) -- The FDA has approved the biologic drug brentuxim... http://t.co/NduSfg4
Medical News: Brentuximab Wins FDA Nod for Hodgkin's, ALCL - in Oncology/Hematology, Lymphoma from MedPage Today
medpagetoday.com — “The FDA has approved the biologic drug brentuximab vedotin (Adcetris) for treating Hodgkin's lymphoma and a rare cousin, systemic anaplastic large-cell lymphoma (ALCL).” View full resource at medpagetoday.com
Most Recently Shared on August 19, 2011 at 7:48 pm By:
Brentuximab Wins FDA Nod for Hodgkin's, ALCL http://t.co/DiEFoJO
Advertisement
